Previous 10 | Next 10 |
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Hyperfine, Inc. 2021 Q4 - Results - Earnings Call Presentation
Hyperfine, Inc. (HYPR) Q4 2021 Earnings Conference Call March 23, 2022 4:30 P.M. ET Company Participants Dave Scott - President and Chief Executive Officer Alok Gupta - Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Anthony Petrone - Mizuho Group Presentation ...
Hyperfine press release (NASDAQ:HYPR): Q4 GAAP EPS of -$2.73. Revenue of $0.44M (+109.5% Y/Y). Cash and cash equivalents totaled $188.498 million as of December 31, 2021. For further details see: Hyperfine GAAP EPS of -$2.73, revenue of $0.44M
GUILFORD, Conn., March 23, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced fourth quarter and full year 2021 financial results and provided a bus...
Hyperfine has developed the world’s first portable MRI system that can acquire images from a patient’s bedside. The Company is founded by serial inventor, Dr. Jonathan Rothberg. The Company recently consummated a business combination and has filed S-1 for the resale ...
GUILFORD, CT, March 03, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the fourth quarter and full year 2021 on Wednesday, March 23,...
GUILFORD, Conn., March 01, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, today announced that the company will be participating in the upcoming 42 nd Annual Co...
GUILFORD, Conn. and MOOSE FACTORY, Ontario, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc . (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen's University and Kingston Health Scie...
GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, today announced the appointment of Dr. Chip Truwit as senior medical director. For more than 30 years, Tru...
Gainers: Palisade Bio (NASDAQ:PALI) +23%. Pharming Group (NASDAQ:PHAR) +14%. Entasis Therapeutics (NASDAQ:ETTX) +13%. Epizyme (NASDAQ:EPZM) +11%. IceCure Medical (NASDAQ:ICCM) +10%. Losers: LogicBio Therapeutics (NASDAQ:LOGC) -50%. Pardes Bios...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...